4.6 Letter

Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed

Related references

Note: Only part of the references are listed.
Letter Dermatology

Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy

R. Maglie et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center

Vieri Grandi et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)